MLMin Jung Lee

Min Jung Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Min Jung Lee has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Hong-Kyu Kim

    Health Screening and Promotion Center, Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

    7 shared publications
  • Eun Hee Kim

    Subdivision of Endocrinology and Metabolism, Health Screening and Promotion Center, Asan Medical Center, Seoul, Korea

    5 shared publications
  • Woo Je Lee

    Subdivision of Endocrinology and Metabolism, Health Screening and Promotion Center, Asan Medical Center, Seoul, Korea

    5 shared publications
  • Chang Hee Jung

    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

    4 shared publications
  • Sung‐Jin Bae

    Subdivision of Endocrinology and Metabolism Health Screening and Promotion Center Asan Medical Center, University of Ulsan College of Medicine Seoul Republic of Korea

    3 shared publications
  • Chang Hee Jung

    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

    2 shared publications

Latest Publications

  • Open Access

    Association of Abdominal Myosteatosis and Visceral Fat Obesity with Arterial Stiffness

    by Min Jung Lee, Hong-Kyu Kim, Eun Hee Kim, Sung Jin Bae, Hyo-Jung Nam, Sang Hoon Lee, Chang Hee Jung, Woo Je Lee

    Background: Arterial stiffness with aging predicts cardiovascular diseases (CVDs) and target organ damage. While sarcopenia has been linked to arterial stiffness, the association of myosteatosis and visceral adiposity with arterial stiffness remains underexplored. As age-related fat redistribution, including myosteatosis and visceral obesity, often precedes overt sarcopenia, their early evaluation may be beneficial in preventing arterial stiffness. Therefore, this cross-sectional study aimed to assess whether myosteatosis and visceral obesity are associated with increased arterial stiffness.Methods: A total of 6,004 subjects without CVD who underwent abdominal computed tomography and brachial-ankle pulse wave velocity (baPWV) between 2012 and 2013 during health examinations were included. Visceral fat area and total abdominal muscle area (TAMA) were measured at the L3 vertebral level. Muscle quality was assessed using the normal attenuation muscle area (NAMA)/TAMA index, where a lower value indicates a reduced proportion of healthy muscle (NAMA) and a higher presence of myosteatosis.Results: After adjusting for multiple cardiovascular risk factors, including myosteatosis, visceral obesity was significantly associated with elevated baPWV in men (odds ratio [OR]=1.32; 95% confidence interval [CI]=1.10 to 1.60; P=0.004). In contrast, in women, myosteatosis was significantly associated with elevated baPWV in a fully adjusted model that included visceral obesity (OR=3.26; 95% CI=1.13 to 9.44; P=0.029).Conclusion: Ectopic fat infiltration, including visceral obesity and myosteatosis, was significantly associated with increased arterial stiffness. Notably, visceral obesity was significantly associated with elevated baPWV in men, while myosteatosis was significantly associated with elevated baPWV in women after adjustment.

  • Open Access

    Effect of Helicobacter pylori Eradication on Metabolic Parameters and Body Composition including Skeletal Muscle Mass: A Matched Case-Control Study

    by Suh Eun Bae, Kee Don Choi, Jaewon Choe, Min Jung Lee, Seonok Kim, Ji Young Choi, Hana Park, Jaeil Kim, Hye Won Park, Hye-Sook Chang, et al.

    Suh Eun Bae, Kee Don Choi, Jaewon Choe, Min Jung Lee, Seonok Kim, Ji Young Choi, Hana Park, Jaeil Kim, Hye Won Park, Hye-Sook Chang, Hee Kyong Na, Ji Yong Ahn, Kee Wook Jung, Jeong Hoon Lee, Do Hoon Kim, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl240494


  • Open Access

    The Impact of Myosteatosis on Cardiac Function in a Healthy Population: Insights from Abdominal CT Imaging

    by Myung Jin Kim, Hyo-Jung Nam, Yun Kyung Cho, Eun Hee Kim, Min Jung Lee, Woo Je Lee, Hong-Kyu Kim, Chang Hee Jung

    Background: Ectopic fat deposition in skeletal muscle, termed myosteatosis, is a key factor in insulin resistance and contributes to various metabolic disturbances. This study evaluated the association between myosteatosis, assessed via abdominal computed tomography, and cardiac function in an asymptomatic Korean population. Methods: This cross-sectional study included 7,716 participants (4,902 [63.5%] men and 2,814 [36.5%] women, mean age 53.2 ± 8.0) who underwent routine health check-ups at Asan Medical Center (Seoul, Korea). Myosteatosis was evaluated by segmenting the total abdominal muscle area (TAMA) at the L3 vertebral level into normal-attenuation muscle area (NAMA), low-attenuation muscle area (LAMA), and inter-/intra-muscular adipose tissue (IMAT). Patients were categorized into quartiles based on the NAMA/TAMA index, calculated by dividing the NAMA by TAMA and multiplying by 100. Cardiac function was assessed by transthoracic echocardiography. Results: Higher NAMA/TAMA index levels were associated with decreased absolute values of the E/E’ ratio and increased E/A ratio in both men and women. Multiple linear regression analysis revealed a significant correlation between the NAMA/TAMA index and both the E/A and E/E’ ratios after adjusting for covariates. No significant correlation was found with left ventricular (LV) ejection fraction or LV mass index. Conclusions: The degree of myosteatosis was significantly associated with diastolic function in an asymptomatic population, while systolic function remained unaffected.

  • Association between sarcopenic obesity and poor muscle quality based on muscle quality map and abdominal computed tomography

    by Yun Kyung Cho, Han Na Jung, Eun Hee Kim, Min Jung Lee, Joong‐Yeol Park, Woo Je Lee, Hong‐Kyu Kim, Chang Hee Jung

    Objective: This study evaluated whether sarcopenic obesity is closely associated with muscle quality using abdominal computed tomography.Methods: This cross‐sectional study included 13,612 participants who underwent abdominal computed tomography. The cross‐sectional area of the skeletal muscle was measured at the L3 level (total abdominal muscle area [TAMA]) and segmented into normal attenuation muscle area (NAMA, +30 to +150 Hounsfield units), low attenuation muscle area (−29 to +29 Hounsfield units), and intramuscular adipose tissue (−190 to −30 Hounsfield units). The NAMA/TAMA index was calculated by dividing NAMA by TAMA and multiplying by 100, and the lowest quartile of NAMA/TAMA index was defined as myosteatosis (p < 0.001) than the control group without sarcopenia or obesity. Compared with the control group, the odds ratio (95% CI) for having myosteatosis was 3.70 (2.87–4.76) for participants with sarcopenic obesity after adjusting for age, sex, smoking, drinking, exercise, hypertension, diabetes, low‐density lipoprotein cholesterol, and high‐sensitivity C‐reactive protein.Conclusions: Sarcopenic obesity is significantly associated with myosteatosis, which is representative of poor muscle quality.


  • Comparison of muscle mass and quality between metabolically healthy and unhealthy phenotypes

    by Hong‐Kyu Kim, Min Jung Lee, Eun Hee Kim, Sung‐Jin Bae, Kyung Won Kim, Chul‐Hee Kim

    Objective: The aim of this study was to examine whether higher skeletal muscle mass is associated with a metabolically healthy phenotype and whether muscle quality affects metabolic health.Methods: This cross‐sectional analysis included 20,659 participants (7,966 women) who underwent abdominal computed tomography scans during health checkups. The total abdominal muscle area (TAMA) on the third lumbar vertebral level was demarcated. Intermuscular adipose tissue and skeletal muscle area were measured. The skeletal muscle area was divided into normal attenuation muscle area (NAMA) and low attenuation muscle area (LAMA). The NAMA/TAMA index was calculated. The metabolically unhealthy phenotype was defined as having two or more components of metabolic syndrome or the presence of hypertension or diabetes.Results: TAMA and skeletal muscle area were not significantly different or even lower in metabolically healthy phenotypes compared with metabolically unhealthy phenotypes. However, metabolically healthy phenotypes had significantly higher NAMA (except in women with obesity) and NAMA/TAMA index than in the metabolically unhealthy phenotypes. In people without obesity, lower NAMA/TAMA index was independently associated with higher risk of the metabolically unhealthy phenotype in the fully adjusted model.Conclusions: The metabolically healthy phenotypes had more good‐quality muscles than did the metabolically unhealthy phenotypes. These results suggest that not only muscle mass but also muscle quality (i.e., degree of myosteatosis) are associated with metabolic health.


  • The Authors' Reply: ‘The way fat‐free mass is reported may change the conclusions regarding its protective effect on metabolic health.’ by Legace et al.

    by Min Jung Lee, Eun‐Hee Kim, Sung‐Jin Bae, Jaewon Choe, Chang Hee Jung, Woo Je Lee, Hong‐Kyu Kim


  • Protective role of skeletal muscle mass against progression from metabolically healthy to unhealthy phenotype

    by Min Jung Lee, Eun‐Hee Kim, Sung‐Jin Bae, Jaewon Choe, Chang Hee Jung, Woo Je Lee, Hong‐Kyu Kim

    Summary: Objective: Metabolically healthy individuals are known to be resistant to cardiovascular disease development. However, a considerable fraction of those individuals shows deteriorated metabolic health over time. Although skeletal muscle is the primary insulin‐responsive target organ, a longitudinal investigation of the skeletal muscle mass in relation to the development of metabolically unhealthy phenotype has not been performed. We aimed to evaluate whether greater skeletal muscle mass is an independent protective factor for the development of metabolically unhealthy phenotype.Design, Participants and Measurements: We conducted a retrospective cohort study with 9033 metabolically healthy volunteers who underwent routine health examinations in 2012 and a follow‐up examination in 2016. Obesity was defined as Asian‐Pacific body mass index criterion ≥25 kg/m2. Subjects with fewer than two risk factors (elevated blood pressure, triglyceride, glucose, high‐sensitivity C‐reactive protein, insulin resistance and decreased high‐density lipoprotein cholesterol levels) were characterized as metabolically healthy using Wildman criteria.Results: At the 4‐year follow‐up, approximately one‐fourth of the nonobese participants and half of the participants with obesity showed metabolic deterioration. In nonobese men and women, higher appendicular skeletal muscle mass (ASM)/weight at baseline was significantly associated with decreased risk of metabolic deterioration. Compared to the lowest quartile of ASM/weight, the adjusted odds ratios (95% confidence intervals) of the highest quartile were 0.68 (0.52‐0.89) in nonobese men and 0.64 (0.46‐0.90) in nonobese women. However, this association was not observed in obese subjects.Conclusions: Greater skeletal muscle mass at baseline is significantly associated with maintenance of metabolically healthy status, especially in nonobese individuals.


  • Open Access

    Erratum for: Association of metabolically healthy obesity with subclinical coronary atherosclerosis in a korean population

    by Chang Hee Jung, Min Jung Lee, Jenie Yoonoo Hwang, Jung Eun Jang, Jaechan Leem, Dong Hyun Yang, Joon-Won Kang, Eun Hee Kim, Joong-Yeol Park, Hong-Kyu Kim, et al.